New approach holds promise for cystic fibrosis lung infection cureSeptember 23rd, 2008 - 2:42 pm ICT by ANI
Washington, Sept 23 (ANI): Researchers from the University of Calgary have suggested a new approach that may help in treating severe lung infections in people with cystic fibrosis (CF).
Pseudomonas aeruginosa is a common bacterium associated with severe lung infections and is a constant threat to the health of CF patients.
The research team led by Michael Surette, Professor of Medicine at the University of Calgary has found that a group of previously overlooked and often undetected bacteria, the Streptococcus milleri group (SMG), compounds the danger of Pseudomonas aeruginosa.
Currently, doctors have treated Pseudomonas with antibiotics, however, this bacteria is gradually becoming treatment resistant.
The researchers suggest that simply targeting SMG can help treat severe lung infections.
While testing the new approach, the research team found that patients treated with SMG-targeted therapies quickly returned to a stable state.
“This is important new information,” said Surette.
“In our small patient group, the laboratory findings have been used to guide treatment, with positive results,” he added.
Initial study results show that it may also be a treatment option for individuals with chronic lung infections unrelated to CF.
“These findings underline the importance of supporting CF research,” said Cathleen Morrison, Chief Executive Officer of the Canadian Cystic Fibrosis Foundation.
“In this case, laboratory research has been translated rapidly into actual treatment, helping people with cystic fibrosis fight back against aggressive infections,” she added.
These findings are published in Proceedings of the National Academy of Science USA. (ANI)
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- 'Walking' properties of bacteria discovered - Oct 08, 2010
- Eat candies to ward off rare, but deadly infections - Jan 05, 2010
- Growth defects in patients with cystic fibrosis 'may start before birth' - Nov 10, 2010
- Boffins come closer to understanding how cystic fibrosis causes lung disease - Apr 29, 2010
- Drug targets defective protein that causes cystic fibrosis - Nov 18, 2010
- Studying spacebound bacteria may inspire Earthbound remedies - Mar 22, 2011
- Protein involved in cystic fibrosis linked to chronic lung diseases - Dec 30, 2010
- Disinfectants likely to promote growth of superbugs - Dec 28, 2009
- How bacteria resist attack - Nov 02, 2009
- New discovery may help treatment of multi-drug resistant infections - Jan 06, 2011
- Nutrition-starved bugs become resistant to antibiotics - Nov 18, 2011
- Microbes' tricks to kill other bugs may help fight disease - Jul 26, 2011
- Soon, cold plasma jets to replace antibiotics - Dec 16, 2010
- New bacterial foe in cystic fibrosis identified - Oct 02, 2010
Tags: canadian cystic fibrosis, canadian cystic fibrosis foundation, cathleen morrison, cf patients, cf research, chief executive officer, chronic lung infections, cystic fibrosis, cystic fibrosis foundation, initial study results, laboratory findings, lung infection, national academy of science, national academy of science usa, patient group, proceedings of the national academy of science, stable state, streptococcus milleri group, surette, university of calgary